Sinusitis drugs market size to increase by USD 801.39 million: 40% growth to originate from North America - Technavio

NEW YORK, Dec. 14, 2022 /PRNewswire/ -- The Sinusitis Drugs Market by Product, Disease Type, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 6.23% and register an incremental growth of USD 801.39 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report.

By region, the global sinusitis drugs market is segmented into North America, Europe, Asia, and Rest of World (ROW) will account for 40% of the market's growth during the forecast period. The increased investments in R&D by large pharmaceutical companies and the presence of a proper regulatory framework for the approval of new drugs are driving the growth of the regional market.

The sinusitis drugs market report includes information on the key products and recent developments of leading vendors, including:

• AbbVie Inc.: The company offers sinusitis drugs such as RINVOQ upadacitinib.
• Alembic Pharmaceuticals Ltd.: The company offers sinusitis drugs such as WIKORYL nasal drops.
• Bayer AG: The company offers sinusitis drugs such as Bayer Select sinus pain relief tablets.
• Dr Reddys Laboratories Ltd.: The company offers sinusitis drugs such as TOSYMRA sumatriptan nasal spray.
• Fresenius SE and Co. KGaA: The company offers sinusitis drugs such as Moxifloxacin.

• To gain access to more vendor profiles available with Technavio, buy the report!

The market is driven by factors such as the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions. However, the surgical intervention used for sinusitis management is hindering the market growth.

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample

• By Product, the market is segmented into steroid nasal sprays, antibiotics, decongestants, and other drugs. The steroid nasal sprays segment accounted for the largest share of the market during the forecast period.
• By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 40% of the market's growth during the forecast period.

The Africa HIV treatment drugs market size is projected to grow by USD 321.6 million from 2022 to 2027, and the market's growth momentum will accelerate at a CAGR of 3.76%. This report extensively covers market segmentation by drug class (reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, fusion inhibitors, and coreceptor antagonists), route of administration (oral drugs and injectable drugs), and geography (APAC, North America, Europe, Middle East and Africa, and South America).

The Infectious Disease Market size is projected to grow by USD 104.81 billion from 2022 to 2027, and the market's growth momentum will accelerate at a CAGR of 12.49%. This report extensively covers market segmentation by product (drugs and vaccines), end-user (hospital, multispecialty clinic, and others), and geography (APAC, North America, Europe, Middle East, and Africa, and South America).

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this sinusitis drugs market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the sinusitis drugs market between 2023 and 2027
• Precise estimation of the size of the sinusitis drugs market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the sinusitis drugs industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of sinusitis drugs market vendors

Browse for Technavio "Health Care" Research Reports

Table of contents:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Disease Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global sinusitis drugs market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global sinusitis drugs market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 Disease type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Disease type Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Steroid nasal sprays - Market size and forecast 2022-2027
• Exhibit 34: Chart on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)

• 6.4 Antibiotics - Market size and forecast 2022-2027
• Exhibit 38: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)

• 6.5 Decongestants - Market size and forecast 2022-2027
• Exhibit 42: Chart on Decongestants - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Decongestants - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Decongestants - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Decongestants - Year-over-year growth 2022-2027 (%)

• 6.6 Other drugs - Market size and forecast 2022-2027
• Exhibit 46: Chart on Other drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Other drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Other drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Other drugs - Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by Product 
• Exhibit 50: Market opportunity by Product ($ million)

7 Market Segmentation by Disease Type

• 7.1 Market segments 
• Exhibit 51: Chart on Disease Type - Market share 2022-2027 (%)
• Exhibit 52: Data Table on Disease Type - Market share 2022-2027 (%)

• 7.2 Comparison by Disease Type 
• Exhibit 53: Chart on Comparison by Disease Type
• Exhibit 54: Data Table on Comparison by Disease Type

• 7.3 Acute sinusitis - Market size and forecast 2022-2027
• Exhibit 55: Chart on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Acute sinusitis - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Acute sinusitis - Year-over-year growth 2022-2027 (%)

• 7.4 Chronic sinusitis - Market size and forecast 2022-2027
• Exhibit 59: Chart on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Chronic sinusitis - Year-over-year growth 2022-2027 (%)

• 7.5 Sub-acute sinusitis - Market size and forecast 2022-2027
• Exhibit 63: Chart on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Disease Type 
• Exhibit 67: Market opportunity by Disease Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027
• Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027
• Exhibit 105: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 AbbVie Inc. 
• Exhibit 116: AbbVie Inc. - Overview
• Exhibit 117: AbbVie Inc. - Product / Service
• Exhibit 118: AbbVie Inc. - Key offerings

• 12.4 Alembic Pharmaceuticals Ltd. 
• Exhibit 119: Alembic Pharmaceuticals Ltd. - Overview
• Exhibit 120: Alembic Pharmaceuticals Ltd. - Product / Service
• Exhibit 121: Alembic Pharmaceuticals Ltd. - Key offerings

• 12.5 Bayer AG 
• Exhibit 122: Bayer AG - Overview
• Exhibit 123: Bayer AG - Business segments
• Exhibit 124: Bayer AG - Key offerings
• Exhibit 125: Bayer AG - Segment focus

• 12.6 Dr Reddys Laboratories Ltd. 
• Exhibit 126: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 127: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 128: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 129: Dr Reddys Laboratories Ltd. - Segment focus

• 12.7 Fresenius SE and Co. KGaA 
• Exhibit 130: Fresenius SE and Co. KGaA - Overview
• Exhibit 131: Fresenius SE and Co. KGaA - Business segments
• Exhibit 132: Fresenius SE and Co. KGaA - Key news
• Exhibit 133: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 134: Fresenius SE and Co. KGaA - Segment focus

• 12.8 GlaxoSmithKline Plc 
• Exhibit 135: GlaxoSmithKline Plc - Overview
• Exhibit 136: GlaxoSmithKline Plc - Business segments
• Exhibit 137: GlaxoSmithKline Plc - Key offerings
• Exhibit 138: GlaxoSmithKline Plc - Segment focus

• 12.9 Hikma Pharmaceuticals Plc 
• Exhibit 139: Hikma Pharmaceuticals Plc - Overview
• Exhibit 140: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 141: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 142: Hikma Pharmaceuticals Plc - Segment focus

• 12.10 Johnson and Johnson 
• Exhibit 143: Johnson and Johnson - Overview
• Exhibit 144: Johnson and Johnson - Business segments
• Exhibit 145: Johnson and Johnson - Key news
• Exhibit 146: Johnson and Johnson - Key offerings
• Exhibit 147: Johnson and Johnson - Segment focus

• 12.11 Merck and Co. Inc. 
• Exhibit 148: Merck and Co. Inc. - Overview
• Exhibit 149: Merck and Co. Inc. - Business segments
• Exhibit 150: Merck and Co. Inc. - Key news
• Exhibit 151: Merck and Co. Inc. - Key offerings
• Exhibit 152: Merck and Co. Inc. - Segment focus

• 12.12 Neopharma Corp. 
• Exhibit 153: Neopharma Corp. - Overview
• Exhibit 154: Neopharma Corp. - Product / Service
• Exhibit 155: Neopharma Corp. - Key news
• Exhibit 156: Neopharma Corp. - Key offerings

• 12.13 Novartis AG 
• Exhibit 157: Novartis AG - Overview
• Exhibit 158: Novartis AG - Business segments
• Exhibit 159: Novartis AG - Key offerings
• Exhibit 160: Novartis AG - Segment focus

• 12.14 Pfizer Inc. 
• Exhibit 161: Pfizer Inc. - Overview
• Exhibit 162: Pfizer Inc. - Product / Service
• Exhibit 163: Pfizer Inc. - Key news
• Exhibit 164: Pfizer Inc. - Key offerings

• 12.15 Sanofi SA 
• Exhibit 165: Sanofi SA - Overview
• Exhibit 166: Sanofi SA - Business segments
• Exhibit 167: Sanofi SA - Key news
• Exhibit 168: Sanofi SA - Key offerings
• Exhibit 169: Sanofi SA - Segment focus

• 12.16 Sun Pharmaceutical Industries Ltd. 
• Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings

• 12.17 Teva Pharmaceutical Industries Ltd. 
• Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 178: Inclusions checklist
• Exhibit 179: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 180: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 181: Research methodology
• Exhibit 182: Validation techniques employed for market sizing
• Exhibit 183: Information sources

• 13.5 List of abbreviations 
• Exhibit 184: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio